Johnson & Johnson has advised its shareholders to reject a 'mini-tender' offer made by TRC Capital Investment. The healthcare giant has expressed concerns about the unsolicited offer and believes it is not in the best interest of its shareholders.
TRC Capital Investment, a private investment firm, recently made a tender offer to purchase up to 1 million shares of Johnson & Johnson's common stock at a price below the market value. Johnson & Johnson has emphasized that this offer is significantly below the current market price of its shares.
